Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Renal Cell Carcinoma (RCC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07647744
What this trial is testing

To Evaluate the Safety and Tolerability of Anti-Human CD70 T-Cell Injection in Subjects With Advanced/Metastatic Renal Cancer

Who this might be right for
Renal Cell Carcinoma (RCC)
Hrain Biotechnology Co., Ltd. 18
Testing effectiveness (Phase 2)UnknownNCT05440045
What this trial is testing

A Clinical Study of 6MW3211 in Patients With Renal Cancer

Who this might be right for
Advanced Clear Cell Renal Cell Carcinoma
Mabwell (Shanghai) Bioscience Co., Ltd. 30
Testing effectiveness (Phase 2)Looking for participantsNCT04977453
What this trial is testing

GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorCervical Cancer+3 more
GI Innovation, Inc. 317
Early research (Phase 1)Active Not RecruitingNCT05789069
What this trial is testing

HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

Who this might be right for
Renal Cell CarcinomaMelanomaNon Small Cell Lung Cancer+2 more
HiFiBiO Therapeutics 83
Testing effectiveness (Phase 2)Looking for participantsNCT07188896
What this trial is testing

Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)

Who this might be right for
Advanced Renal Cell Carcinoma (aRCC)Metastatic Renal Cell Carcinoma ( mRCC)Clear Cell Renal Cell Carcinoma (ccRCC)
Brian Rini 120
Not applicableStudy completedNCT04682587
What this trial is testing

To Examine the Effects of Axitinib Dose Reduction and Interruption for Adverse Event Management Among Patients Receiving Axitinib in for the Treatment of Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Pfizer 481
Testing effectiveness (Phase 2)UnknownNCT02689167
What this trial is testing

Study to Assess Various Sunitinib Schedules in Renal Cell Carcinoma

Who this might be right for
Kidney NeoplasmsMetastatic Renal Cell Cancer
Centre Hospitalier Universitaire de Besancon 226
Early research (Phase 1)Study completedNCT01497444
What this trial is testing

Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Kidney CancerLiver Cancer
Alliance for Clinical Trials in Oncology 24
Not applicableStudy completedNCT01917214
What this trial is testing

A Retrospective Real World Analysis Of Sutent In Patients With Metastatic Renal Cell Carcinoma In Community And Academic Centers To Assess The Impact Of Dose Variation On Duration Of Response And Overall Survival

Who this might be right for
Metastatic Renal Cell Carcinoma
Pfizer 212
Early research (Phase 1)Ended earlyNCT02608125
What this trial is testing

A Dose Escalation Study in Solid Tumors and a Dose Expansion Study of PRN1371 in Adult Patients With Metastatic Urothelial Carcinoma

Who this might be right for
Solid TumorsMetastatic Urothelial Carcinoma & Renal Pelvis & Ureter
Principia Biopharma, a Sanofi Company 45
Early research (Phase 1)Study completedNCT00635791
What this trial is testing

Phase I Study of Vorinostat and Sorafenib in Advanced Cancer

Who this might be right for
Malignant Solid TumourRenal Cell CarcinomaNon Small Cell Lung Carcinoma
University of Colorado, Denver 36
Early research (Phase 1)Looking for participantsNCT06792552
What this trial is testing

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsPlatinum Resistant Ovarian CancerFallopian Tube Cancer+5 more
NextCure, Inc. 738
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Large-scale testing (Phase 3)Active Not RecruitingNCT02811861
What this trial is testing

Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Eisai Inc. 1,069
Testing effectiveness (Phase 2)Study completedNCT03602079
What this trial is testing

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Who this might be right for
HER2-positive Breast CancerHER2 Gene MutationHER-2 Gene Amplification+41 more
Klus Pharma Inc. 49
Early research (Phase 1)Looking for participantsNCT07634380
What this trial is testing

Sitagliptin With Pembro in RCC and Melanoma

Who this might be right for
Advanced Renal Cell CarcinomaAdvanced Melanoma
Fernando Maciel Barbosa 64
Early research (Phase 1)Study completedNCT02145559
What this trial is testing

A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors

Who this might be right for
Breast NeoplasmsLung NeoplasmsCancer of Liver+2 more
University of Chicago 24
Large-scale testing (Phase 3)Looking for participantsNCT07197580
What this trial is testing

Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC

Who this might be right for
ccRCCRenal Cell Carcinoma (Kidney Cancer)Renal Cell Carcinoma (RCC)+3 more
Telix Pharmaceuticals (Innovations) Pty Limited 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07470840
What this trial is testing

SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma

Who this might be right for
Locally Advanced or Metastatic Renal Cell Carcinoma
Fujian Cancer Hospital 27
Testing effectiveness (Phase 2)Study completedNCT00137423
What this trial is testing

Study Of SU011248 (Sunitinib) Given In A Continuous Daily Regimen In Patients With Advanced Renal Cell Cancer

Who this might be right for
Carcinoma, Renal Cell Metastasis
Pfizer 107
Next Page